During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells within the tissue. But the damage doesn’t end after the crushing pain subsides. Instead, the heart’s walls thin out, the organ becomes enlarged, and scar tissue forms. If nothing is done, the patient can eventually experience heart failure. But scientists now report they have developed gels that, in animal tests, can be injected into the heart to shore up weakened areas and prevent heart failure.
The researchers will present their work today at the 252nd National Meeting & Exposition of the American Chemical Society (ACS). ACS, the world’s largest scientific society, is holding the meeting here through Thursday. It features more than 9,000 presentations on a wide range of science topics. A brand-new video on the research is available at http://bit.ly/ACShydrogels.
Heart attacks strike 750,000 people each year in the U.S., according to the American Heart Association. And more than 5 million U.S. residents are living with heart failure, with symptoms that progress from fatigue and shortness of breath to eventual death. “Heart failure is a huge problem, and few therapies are available for these patients,” says Jason A. Burdick, Ph.D., leader of the study.
Treatments include lifestyle changes, medication, implants or heart transplants. Burdick, who is at the University of Pennsylvania (Penn), explains that these options often don’t work well or, in the case of transplants, are hard to come by. So scientists are pursuing other treatment methods. For instance, researchers at other institutions have done animal studies in which they injected cells into the damaged section of the heart to try to repair damage. To prevent the cells from leaking out, those researchers embedded them in biodegradable “hydrogels” — water-swollen networks of polymer chains with a consistency similar to Jell-OTM. But the scientists noticed something odd when they ran control experiments in which they injected the hydrogel without added cells: Some of the animals’ hearts still showed improvement compared with untreated animals.
Based on those findings, a handful of labs are now experimenting with hydrogel treatments, including two materials that are in clinical trials. Neither is from Burdick’s lab, but as he notes, “It’s important we all keep moving forward to figure out how this therapy could be used, because it’s different than any current treatment.” In addition, different types of hydrogels could suit different patients’ needs.
Some experimental heart attack treatments require surgery to open up the chest, but the two hydrogel materials already in clinical trials are injected into the damaged tissue through a long catheter inserted through the skin — eliminating the need for open-chest surgery.
Burdick and his graduate student Christopher B. Rodell, in collaboration with Robert C. Gorman, M.D., also at Penn, are using this same minimally invasive technique in their own work. But his team has gone a step further by identifying properties that would be useful in treating heart attack patients and then designing hydrogels with those properties. For instance, his group developed a hydrogel that forms additional crosslinks between the polymer chains after injection. The resulting material is stiffer and lasts longer than a gel without these additional crosslinks and the gels in clinical trials.
In fact, Burdick’s gel is unique among hydrogels in providing mechanical support to stabilize the damaged area. In sheep studies, this gel limits formation of scar tissue, thinning of the heart’s walls and enlargement of the heart. By preserving the organ’s size, the gels also reduce leakage of blood through the mitral valve. Together, these benefits maintain the heart’s blood-pumping ability and could stave off heart failure.
The team’s materials are based on hyaluronic acid (HA), a type of sugar molecule that occurs naturally in the body. The researchers modified the HA molecules by attaching adamantane and cyclodextrin groups to allow the gels to flow through catheters, and they added thiol and methacrylate groups to enable post-injection cross-linking to stiffen the hydrogel. Once the researchers finalize the hydrogel formulation and delivery method, they hope to partner with a catheter firm to bring a product to market. Burdick’s team and other research groups are also designing hydrogels that contain drugs or cells that can repair heart tissue.
This research is being presented at a meeting of the American Chemical Society.
Learn more: After the heart attack: Injectable gels could prevent future heart failure
The Latest on: Injectable gels
[google_news title=”” keyword=”Injectable gels” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Injectable gels
- Innovative peptide-based hydrogel therapy for virus preventionon April 24, 2024 at 9:43 am
Vaccines remain the gold standard of protection against dangerous pathogens, but take considerable time and vast resources to develop.
- What Are the Most Effective Psoriasis Therapy Options?on April 23, 2024 at 6:01 pm
With many treatment options for psoriasis, how do you know which ones are right for you? Here are the most effective psoriasis therapy options to consider.
- Ibuprofen - Uses, Side Effects, and Moreon April 23, 2024 at 5:00 pm
Ibuprofen injection may also be used with an opioid pain medicine, like hydrocodone or morphine, to treat severe pain. Ibuprofen may also be used for other conditions as determined by your ...
- Questcor Pharmaceuticals,on April 23, 2024 at 5:00 pm
The company's primary product is H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations ...
- FDA approves Lumicell’s fluorescent system for highlighting residual breast cancer tissueon April 19, 2024 at 8:08 am
The FDA has granted a groundbreaking approval to a fluorescent light system that illuminates leftover breast cancer tissue in real-time during surgery—to help ensure a thorough removal of the tumor | ...
- Dermal Fillers Market Future Prospects, Industry-specific Challenges, Industry Projections, Sizes and Shares by 2032on April 18, 2024 at 2:32 pm
Dermal Fillers Market is valued at approximately USD 5.05 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. Dermal fillers are ...
- Temple Filler: Everything to Know About the Buzzy Treatmenton April 16, 2024 at 6:33 pm
Curious about temple filler? An expert answers everything to know about the treatment, like pricing and who is a good candidate.
- What to know about the counterfeit, mishandled Botox injections causing harmful effects across USon April 16, 2024 at 2:07 pm
The CDC and FDA are investigating after counterfeit and mishandled Botox injections have caused harmful reactions across the U.S. Here's what you need to know.
- 11 Best Water-Based Moisturizers in 2024on April 16, 2024 at 6:44 am
Branded content. Us Weekly has affiliate partnerships so we may receive compensation for some links to products and services. There’s nothing dry, parched skin loves more than a wholesome water-based ...
- Are injectable moisturisers good for your skin?on April 12, 2024 at 7:38 pm
In all probability, you have heard about injectable moisturisers and the power it has to transform your skin. But should you get one?
via Bing News